Promino Nutritional Sciences reported a significant improvement in its 2025 financial results, with revenue rising to over $2.1 million from about $260,600 in 2024, and net loss shrinking from $7.1 million to $3.0 million. The company expanded distribution of its core product, Rejuvenate Muscle Health™, supported by growth in e-commerce and retail channels. Cost management efforts reduced expenses to $3.4 million from $6.3 million the previous year. Promino also enhanced its financial reporting and governance after lifting a cease-trade order and initiated a large production run to meet anticipated demand. These steps position the company for disciplined growth and operational strengthening in the muscle health nutrition market.
Following Shell's interim dividend payment for Q1 2026 on June 29, several senior executives, including CEO Wael Sawan and CFO Sinead Gorman, acquired shares through dividend reinvestment plans. These shares were obtained in respect of shares previou...
The global aliphatic hydrocarbon solvents and thinners market is projected to grow from $5.26 billion in 2026 to $6.81 billion by 2032, at a CAGR of 4.4%. Growth is fueled by rising demand in coatings, adhesives, and industrial maintenance, with mine...
The global data center semiconductor market is projected to grow from $86.8 billion in 2024 to $265.8 billion by 2029, driven by rising demand for AI-powered servers. The power stage segment will dominate due to its critical role in efficient power d...
The data center direct-to-chip cooling market is projected to grow from $3.33 billion in 2026 to $17.31 billion by 2032, at a CAGR of 26.5%. This growth is driven by the need for precise thermal management in advanced computing, especially for edge c...
The global environmental DNA (eDNA) market is projected to expand from $1.63 billion in 2026 to $5.61 billion by 2031, growing at a 10.2% CAGR. This growth is driven by advanced, non-invasive testing methods that detect species through genetic materi...
